Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP

6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Cyclacel Pharma (CYCC) Misses Q2 EPS by 4c

August 9, 2018 4:52 PM EDT

Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.16), $0.04 worse than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

... More